Ambu A/S (AMBBY)
USD 14.18
(0.0%)
USD 14.18
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 1.02 Billion DKK | 58.85% |
| 2023 | 644 Million DKK | 26.87% |
| 2022 | 492 Million DKK | -12.08% |
| 2021 | 458 Million DKK | -2.76% |
| 2020 | 515 Million DKK | -4.77% |
| 2019 | 542 Million DKK | -10.98% |
| 2018 | 683 Million DKK | 30.84% |
| 2017 | 531 Million DKK | 12.5% |
| 2016 | 434 Million DKK | 28.53% |
| 2015 | 340 Million DKK | 14.97% |
| 2014 | 266 Million DKK | 41.44% |
| 2013 | 164 Million DKK | 2.57% |
| 2012 | 202 Million DKK | 7.66% |
| 2011 | 200.65 Million DKK | 8.19% |
| 2010 | 183.28 Million DKK | 35.03% |
| 2009 | 137.6 Million DKK | 153.18% |
| 2008 | 132.7 Million DKK | -342.41% |
| 2007 | 106.73 Million DKK | -12.32% |
| 2006 | 121.73 Million DKK | 76.34% |
| 2005 | 69.03 Million DKK | 21.82% |
| 2004 | 67.72 Million DKK | -6.62% |
| 2003 | 60.68 Million DKK | 40.89% |
| 2002 | 43.07 Million DKK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 216 Million DKK | 66.41% |
| 2024 Q3 | 270 Million DKK | -6.32% |
| 2024 Q2 | 285 Million DKK | 33.8% |
| 2023 Q1 | 146 Million DKK | 4.29% |
| 2023 Q4 | 183 Million DKK | 3.39% |
| 2023 Q3 | 177 Million DKK | 43.9% |
| 2023 FY | - DKK | 26.87% |
| 2023 Q2 | 123 Million DKK | -15.75% |
| 2022 Q2 | 267 Million DKK | 169.7% |
| 2022 Q1 | 99 Million DKK | 47.76% |
| 2022 Q3 | 130 Million DKK | -51.31% |
| 2022 FY | - DKK | -12.08% |
| 2022 Q4 | 140 Million DKK | 7.69% |
| 2021 Q2 | 169 Million DKK | -7.65% |
| 2021 Q3 | 144 Million DKK | -14.79% |
| 2021 Q4 | 67 Million DKK | -53.47% |
| 2021 Q1 | 183 Million DKK | 56.41% |
| 2021 FY | - DKK | -2.76% |
| 2020 Q4 | 117 Million DKK | -32.37% |
| 2020 Q2 | 210 Million DKK | 92.66% |
| 2020 FY | - DKK | -4.77% |
| 2020 Q1 | 109 Million DKK | 255.71% |
| 2020 Q3 | 173 Million DKK | -17.62% |
| 2019 Q2 | 226 Million DKK | 64.96% |
| 2019 Q1 | 137 Million DKK | -29.74% |
| 2019 FY | - DKK | -10.98% |
| 2019 Q4 | -70 Million DKK | -122.22% |
| 2019 Q3 | 315 Million DKK | 39.38% |
| 2018 Q1 | 112 Million DKK | -21.13% |
| 2018 FY | - DKK | 30.84% |
| 2018 Q2 | 172 Million DKK | 53.57% |
| 2018 Q3 | 204 Million DKK | 18.6% |
| 2018 Q4 | 195 Million DKK | -4.41% |
| 2017 Q2 | 142 Million DKK | 27.93% |
| 2017 FY | - DKK | 12.5% |
| 2017 Q4 | 142 Million DKK | 11.81% |
| 2017 Q3 | 127 Million DKK | -10.56% |
| 2017 Q1 | 111 Million DKK | -26.97% |
| 2016 Q3 | 129 Million DKK | 29.0% |
| 2016 FY | - DKK | 28.53% |
| 2016 Q4 | 152 Million DKK | 17.83% |
| 2016 Q1 | 83 Million DKK | -27.19% |
| 2016 Q2 | 100 Million DKK | 20.48% |
| 2015 Q3 | 50 Million DKK | -67.11% |
| 2015 Q4 | 114 Million DKK | 128.0% |
| 2015 FY | - DKK | 14.97% |
| 2015 Q1 | 54 Million DKK | -56.8% |
| 2015 Q2 | 152 Million DKK | 181.48% |
| 2014 Q3 | 78 Million DKK | 41.82% |
| 2014 Q4 | 125 Million DKK | 60.26% |
| 2014 Q1 | 16 Million DKK | -61.72% |
| 2014 Q2 | 55 Million DKK | 243.75% |
| 2014 FY | - DKK | 41.44% |
| 2013 Q4 | 41.8 Million DKK | 6.91% |
| 2013 FY | - DKK | 2.57% |
| 2013 Q3 | 39.1 Million DKK | -37.34% |
| 2013 Q2 | 62.4 Million DKK | 83.53% |
| 2013 Q1 | 34 Million DKK | -44.92% |
| 2012 Q4 | 61.72 Million DKK | 1.53% |
| 2012 Q1 | 38.3 Million DKK | 77.09% |
| 2012 FY | - DKK | 7.66% |
| 2012 Q2 | 57.9 Million DKK | 51.17% |
| 2012 Q3 | 60.8 Million DKK | 5.01% |
| 2011 Q2 | 94.6 Million DKK | 135.91% |
| 2011 Q1 | 40.1 Million DKK | 7.07% |
| 2011 Q3 | 44.6 Million DKK | -52.85% |
| 2011 Q4 | 21.62 Million DKK | -51.51% |
| 2011 FY | - DKK | 8.19% |
| 2010 Q1 | 37.6 Million DKK | 148.91% |
| 2010 Q4 | 37.45 Million DKK | -34.29% |
| 2010 FY | - DKK | 35.03% |
| 2010 Q3 | 57 Million DKK | -0.7% |
| 2010 Q2 | 57.4 Million DKK | 52.66% |
| 2009 Q4 | 15.1 Million DKK | -68.98% |
| 2009 FY | - DKK | 153.18% |
| 2009 Q1 | 36 Million DKK | 0.0% |
| 2009 Q3 | 48.7 Million DKK | -4.32% |
| 2009 Q2 | 50.9 Million DKK | 41.39% |
| 2008 FY | - DKK | -342.41% |
| 2007 FY | - DKK | -12.32% |
| 2006 FY | - DKK | 76.34% |
| 2005 FY | - DKK | 21.82% |
| 2004 FY | - DKK | -6.62% |
| 2003 FY | - DKK | 40.89% |
| 2002 FY | - DKK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AVITA Medical, Inc. | -39.56 Million USD | 2685.438% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 87986.598% |
| Össur hf. | 137.38 Million USD | -644.644% |
| QHSLab, Inc. | -91.29 Thousand USD | 1120667.842% |
| Wellstar International, Inc. | -1.35 Million USD | 75513.669% |
| Össur hf. | 137.38 Million USD | -644.644% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | -58.46 Thousand USD | 1749984.538% |
| Aurora Spine Corporation | -454.37 Thousand USD | 225242.943% |
| BrainsWay Ltd. | -2.31 Million USD | 44366.551% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 373062.922% |
| Hamilton Thorne Ltd. | 5.52 Million USD | -18427.155% |
| Vivos Inc. | -2.79 Million USD | 36725.368% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 517574.24% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 61410.572% |
| Zecotek Photonics Inc. | -3.44 Million USD | 29819.201% |
| Avitar, Inc. | -1.66 Million USD | 61438.18% |
| Nanomix Corporation | -8.13 Million USD | 12667.927% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | -10366.444% |
| Theraclion SA | -2.05 Million USD | 49983.313% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -1.45 Million USD | 70547.219% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 59511.633% |
| Lombard Medical, Inc. | -28.06 Million USD | 3744.72% |
| ALR Technologies Inc. | -6.4 Million USD | 16083.588% |
| Stratec SE | 39.91 Million USD | -2463.01% |
| Vycor Medical, Inc. | 100.94 Thousand USD | -1013343.23% |
| Heart Tronics, Inc. | -14.85 Million USD | 6985.7% |
| MicroPort Scientific Corporation | -347.57 Million USD | 394.322% |
| VMS Rehab Systems, Inc. | -68.55 USD | 1492341456.674% |
| NewCardio, Inc. | -9.37 Million USD | 11006.966% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 32825.528% |
| Ingen Technologies, Inc. | -8639.00 USD | 11841748.339% |
| Odyssey Group International, Inc. | -2.13 Million USD | 47946.8% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 270087.807% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 144789.759% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 11277.886% |
| IR-Med Inc. | -4.89 Million USD | 21011.693% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 7805.143% |
| Polarean Imaging plc | -11.19 Million USD | 9238.015% |
| United American Healthcare Corporation | -59 Thousand USD | 1733998.305% |
| ECGI Holdings, Inc. | -2.99 Million USD | 34309.104% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 865150.44% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 162691.806% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 199117.558% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | -224212.59% |
| Urologix, Inc. | -6.34 Million USD | 16225.473% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 82642.536% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 133656.668% |
| SS Innovations International, Inc. | -20.37 Million USD | 5120.615% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 459219.102% |
| Smith & Nephew plc | 1 Billion USD | -2.036% |
| NIOX Group Plc | 11.07 Million USD | -9136.937% |
| Fuse Medical, Inc. | 1.83 Million USD | -55639.72% |
| Broncus Holding Corporation | -25.19 Million USD | 4159.715% |
| Brain Scientific Inc. | -7.93 Million USD | 12994.32% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 10993.52% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 5559882.609% |